Two cases of thrombosis or blood clots were recorded in Denmark with one of them reported to have died after an immunization plan using the AstraZeneca vaccine was given to over 140,000 recipient
Following concerns of side effects, Last Tuesday announced the decision to discontinue the use of the AstraZeneca vaccine, thus becoming the first European country to do so.
Although the World Health Organization (WHO) and the European Medical Agency (EMA) recommend that the vaccine produced by Oxford University remain used in inoculation, Danish Health Authority Director Soren Brostrom is determined to agree with the ruling.
More than 12 countries later followed Denmark’s lead, but most returned to use the vaccine after the EMA stressed on the benefits of the vaccine and recommended it was safe and effective.
However, Denmark insisted on its stand to suspend the use of the AstraZeneca vaccine to give way to an investigation conducted by the country’s health authorities.
Since suspending the use of the AstraZeneca vaccine last March, Denmark has continued their immunization plan based on the supply of Pfizer-BioNTech and Moderna.
Based on current records, only eight percent of the country’s total 5.8 million people have received a full COVID-19 vaccine injection, while another 17 percent have only received the first dose.